Last updated
Vanguard Health Care Index Fund (VHT)
Price 286.45元
List of Constituents
VHT Constituents. Through this analysis, you can identify the individual stocks held by the ETF and further analyze their fair value and value range.
| Rank | Ticker | Name | Ratio |
|---|---|---|---|
| 1 | LLY | Eli Lilly & Co. | 10.53% |
| 2 | UNH | UnitedHealth Group Inc. | 8.6% |
| 3 | ABBV | AbbVie Inc. | 5.31% |
| 4 | JNJ | Johnson & Johnson | 4.78% |
| 5 | MRK | Merck & Co. Inc. | 3.89% |
| 6 | TMO | Thermo Fisher Scientific Inc. | 3.79% |
| 7 | DHR | Danaher Corp. | 3.16% |
| 8 | ABT | Abbott Laboratories | 2.98% |
| 9 | AMGN | Amgen Inc. | 2.88% |
| 10 | PFE | Pfizer Inc. | 2.79% |
| 11 | ISRG | Intuitive Surgical Inc. | 2.55% |
| 12 | VRTX | Vertex Pharmaceuticals Inc. | 2.07% |
| 13 | ELV | Anthem Inc. | 2% |
| 14 | REGN | Regeneron Pharmaceuticals Inc. | 1.89% |
| 15 | SYK | Stryker Corp. | 1.81% |
| 16 | BSX | Boston Scientific Corp. | 1.76% |
| 17 | MDT | Medtronic plc | 1.73% |
| 18 | CI | Cigna Corp. | 1.6% |
| 19 | BMY | Bristol-Myers Squibb Co. | 1.56% |
| 20 | GILD | Gilead Sciences Inc. | 1.54% |
| 21 | ZTS | Zoetis Inc. | 1.33% |
| 22 | MCK | McKesson Corp. | 1.31% |
| 23 | CVS | CVS Health Corp. | 1.23% |
| 24 | HCA | HCA Healthcare Inc. | 1.17% |
| 25 | BDX | Becton Dickinson and Co. | 1.13% |
| 26 | IQV | IQVIA Holdings Inc. | 0.72% |
| 27 | HUM | Humana Inc. | 0.71% |
| 28 | AmerisourceBergen Corp. Class A | 0.69% | |
| 29 | CNC | Centene Corp. | 0.67% |
| 30 | A | Agilent Technologies Inc. | 0.67% |
| 31 | IDXX | IDEXX Laboratories Inc. | 0.64% |
| 32 | MRNA | Moderna Inc. | 0.63% |
| 33 | EW | Edwards Lifesciences Corp. | 0.61% |
| 34 | GEHC | GE HealthCare Technologies Inc. | 0.59% |
| 35 | MTD | Mettler-Toledo International Inc. | 0.53% |
| 36 | RMD | ResMed Inc. | 0.51% |
| 37 | BIIB | Biogen Inc. | 0.5% |
| 38 | ALNY | Alnylam Pharmaceuticals Inc. | 0.49% |
| 39 | VEEV | Veeva Systems Inc. Class A | 0.48% |
| 40 | DXCM | DexCom Inc. | 0.42% |
| 41 | CAH | Cardinal Health Inc. | 0.4% |
| 42 | STE | STERIS plc | 0.38% |
| 43 | ZBH | Zimmer Biomet Holdings Inc. | 0.37% |
| 44 | WST | West Pharmaceutical Services Inc. | 0.36% |
| 45 | ILMN | Illumina Inc. | 0.32% |
| 46 | MOH | Molina Healthcare Inc. | 0.32% |
| 47 | WAT | Waters Corp. | 0.32% |
| 48 | HOLX | Hologic Inc. | 0.31% |
| 49 | COO | Cooper Cos. Inc. | 0.3% |
| 50 | BAX | Baxter International Inc. | 0.29% |
| 51 | LH | Labcorp Holdings Inc. | 0.29% |
| 52 | ALGN | Align Technology Inc. | 0.27% |
| 53 | AVTR | Avantor Inc. | 0.27% |
| 54 | DGX | Quest Diagnostics Inc. | 0.26% |
| 55 | BMRN | BioMarin Pharmaceutical Inc. | 0.26% |
| 56 | PKI | PerkinElmer Inc. | 0.25% |
| 57 | VTRS | Viatris Inc. | 0.23% |
| 58 | NBIX | Neurocrine Biosciences Inc. | 0.23% |
| 59 | UTHR | United Therapeutics Corp. | 0.23% |
| 60 | PODD | Insulet Corp. | 0.22% |
| 61 | THC | Tenet Healthcare Corp. | 0.22% |
| 62 | TECH | Bio-Techne Corp. | 0.21% |
| 63 | UHS | Universal Health Services Inc. Class B | 0.21% |
| 64 | CRL | Charles River Laboratories International Inc. | 0.2% |
| 65 | NTRA | Natera Inc. | 0.19% |
| 66 | RPRX | Royalty Pharma plc Class A | 0.17% |
| 67 | INCY | Incyte Corp. | 0.17% |
| 68 | CTLT | Catalent Inc. | 0.17% |
| 69 | TFX | Teleflex Inc. | 0.17% |
| 70 | INSM | Insmed Inc. | 0.17% |
| 71 | MEDP | Medpace Holdings Inc. | 0.16% |
| 72 | SRPT | Sarepta Therapeutics Inc. | 0.15% |
| 73 | HSIC | Henry Schein Inc. | 0.15% |
| 74 | EHC | Encompass Health Corp. | 0.15% |
| 75 | RGEN | Repligen Corp. | 0.14% |
| 76 | SOLV | Solventum Corp. | 0.14% |
| 77 | CHE | Chemed Corp. | 0.13% |
| 78 | EXAS | Exact Sciences Corp. | 0.13% |
| 79 | ENSG | Ensign Group Inc. | 0.13% |
| 80 | LNTH | Lantheus Holdings Inc. | 0.12% |
| 81 | DVA | DaVita Inc. | 0.12% |
| 82 | PCVX | Vaxcyte Inc. | 0.12% |
| 83 | JAZZ | Jazz Pharmaceuticals plc | 0.11% |
| 84 | BIO | Bio-Rad Laboratories Inc. Class A | 0.11% |
| 85 | HALO | Halozyme Therapeutics Inc. | 0.11% |
| 86 | HQY | HealthEquity Inc. | 0.11% |
| 87 | ITCI | Intra-Cellular Therapies Inc. | 0.11% |
| 88 | ACHC | Acadia Healthcare Co. Inc. | 0.1% |
| 89 | BRKR | Bruker Corp. | 0.1% |
| 90 | PEN | Penumbra Inc. | 0.1% |
| 91 | IONS | Ionis Pharmaceuticals Inc. | 0.1% |
| 92 | ELAN | Elanco Animal Health Inc. | 0.1% |
| 93 | GMED | Globus Medical Inc. | 0.1% |
| 94 | EXEL | Exelixis Inc. | 0.1% |
| 95 | CYTK | Cytokinetics Inc. | 0.1% |
| 96 | BPMC | Blueprint Medicines Corp. | 0.1% |
| 97 | GKOS | Glaukos Corp. | 0.1% |
| 98 | OGN | Organon & Co. | 0.09% |
| 99 | XRAY | Dentsply Sirona Inc. | 0.09% |
| 100 | RVMD | REVOLUTION Medicines Inc. | 0.09% |
| 101 | VKTX | Viking Therapeutics Inc. | 0.09% |
| 102 | MASI | Masimo Corp. | 0.08% |
| 103 | OPCH | Option Care Health Inc. | 0.08% |
| 104 | MMSI | Merit Medical Systems Inc. | 0.08% |
| 105 | INSP | Inspire Medical Systems Inc. | 0.07% |
| 106 | Haemonetics Corp. | 0.07% | |
| 107 | CRISPR Therapeutics AG | 0.07% | |
| 108 | Alkermes plc | 0.07% | |
| 109 | Select Medical Holdings Corp. | 0.07% | |
| 110 | TMDX | TransMedics Group Inc. | 0.07% |
| 111 | Guardant Health Inc. | 0.07% | |
| 112 | Perrigo Co. plc | 0.06% | |
| 113 | Arrowhead Pharmaceuticals Inc. | 0.06% | |
| 114 | Neogen Corp. | 0.06% | |
| 115 | Axonics Modulation Technologies Inc. | 0.06% | |
| 116 | Prestige Consumer Healthcare Inc. | 0.06% | |
| 117 | Corcept Therapeutics Inc. | 0.06% | |
| 118 | Integer Holdings Corp. | 0.06% | |
| 119 | KRYS | Krystal Biotech Inc. | 0.06% |
| 120 | RadNet Inc. | 0.06% | |
| 121 | Madrigal Pharmaceuticals Inc. | 0.06% | |
| 122 | Crinetics Pharmaceuticals Inc. | 0.06% | |
| 123 | RNA | Avidity Biosciences Inc. | 0.06% |
| 124 | ROIV | Roivant Sciences Ltd. | 0.06% |
| 125 | Envista Holdings Corp. | 0.05% | |
| 126 | Apellis Pharmaceuticals Inc. | 0.05% | |
| 127 | Brooks Automation Inc. | 0.05% | |
| 128 | Amedisys Inc. | 0.05% | |
| 129 | RARE | Ultragenyx Pharmaceutical Inc. | 0.05% |
| 130 | DOCS | Doximity Inc. Class A | 0.05% |
| 131 | Denali Therapeutics Inc. | 0.05% | |
| 132 | Twist Bioscience Corp. | 0.05% | |
| 133 | CERE | Cerevel Therapeutics Holdings Inc. | 0.05% |
| 134 | CRVL | CorVel Corp. | 0.05% |
| 135 | TG Therapeutics Inc. | 0.05% | |
| 136 | Bridgebio Pharma Inc. | 0.05% | |
| 137 | Hims & Hers Health Inc. | 0.05% | |
| 138 | PROCEPT BioRobotics Corp. | 0.05% | |
| 139 | Biohaven Ltd. | 0.05% | |
| 140 | Novocure Ltd. | 0.04% | |
| 141 | AMN Healthcare Services Inc. | 0.04% | |
| 142 | Premier Inc. Class A | 0.04% | |
| 143 | iRhythm Technologies Inc. | 0.04% | |
| 144 | Intellia Therapeutics Inc. | 0.04% | |
| 145 | Tandem Diabetes Care Inc. | 0.04% | |
| 146 | Progyny Inc. | 0.04% | |
| 147 | Inari Medical Inc. | 0.04% | |
| 148 | ICU Medical Inc. | 0.04% | |
| 149 | LivaNova plc | 0.04% | |
| 150 | Beam Therapeutics Inc. | 0.04% | |
| 151 | Evolent Health Inc. Class A | 0.04% | |
| 152 | RCM | R1 RCM Inc. | 0.04% |
| 153 | PTC Therapeutics Inc. | 0.04% | |
| 154 | Enovis Corp. | 0.04% | |
| 155 | Amicus Therapeutics Inc. | 0.04% | |
| 156 | Xenon Pharmaceuticals Inc. | 0.04% | |
| 157 | Myriad Genetics Inc. | 0.04% | |
| 158 | Apollo Medical Holdings Inc. | 0.04% | |
| 159 | Agios Pharmaceuticals Inc. | 0.04% | |
| 160 | Celldex Therapeutics Inc. | 0.04% | |
| 161 | Axsome Therapeutics Inc. | 0.04% | |
| 162 | Vericel Corp. | 0.04% | |
| 163 | NeoGenomics Inc. | 0.04% | |
| 164 | NUVL | Nuvalent Inc. Class A | 0.04% |
| 165 | Rhythm Pharmaceuticals Inc. | 0.04% | |
| 166 | ADMA Biologics Inc. | 0.04% | |
| 167 | Fortrea Holdings Inc. | 0.04% | |
| 168 | Ideaya Biosciences Inc. | 0.04% | |
| 169 | UFP Technologies Inc. | 0.04% | |
| 170 | Dyne Therapeutics Inc. | 0.04% | |
| 171 | Teladoc Health Inc. | 0.03% | |
| 172 | agilon health Inc. | 0.03% | |
| 173 | Integra LifeSciences Holdings Corp. | 0.03% | |
| 174 | STAAR Surgical Co. | 0.03% | |
| 175 | Privia Health Group Inc. | 0.03% | |
| 176 | CONMED Corp. | 0.03% | |
| 177 | 10X Genomics Inc. Class A | 0.03% | |
| 178 | Patterson Cos. Inc. | 0.03% | |
| 179 | Tilray Inc. | 0.03% | |
| 180 | ACADIA Pharmaceuticals Inc. | 0.03% | |
| 181 | Supernus Pharmaceuticals Inc. | 0.03% | |
| 182 | Novavax Inc. | 0.03% | |
| 183 | Addus HomeCare Corp. | 0.03% | |
| 184 | Ligand Pharmaceuticals Inc. | 0.03% | |
| 185 | Veracyte Inc. | 0.03% | |
| 186 | Certara Inc. | 0.03% | |
| 187 | Amphastar Pharmaceuticals Inc. | 0.03% | |
| 188 | Iovance Biotherapeutics Inc. | 0.03% | |
| 189 | Surgery Partners Inc. | 0.03% | |
| 190 | Syndax Pharmaceuticals Inc. | 0.03% | |
| 191 | Kymera Therapeutics Inc. | 0.03% | |
| 192 | Rocket Pharmaceuticals Inc. | 0.03% | |
| 193 | National HealthCare Corp. | 0.03% | |
| 194 | LeMaitre Vascular Inc. | 0.03% | |
| 195 | MannKind Corp. | 0.03% | |
| 196 | Sotera Health Co. | 0.03% | |
| 197 | SpringWorks Therapeutics Inc. | 0.03% | |
| 198 | Morphic Holding Inc. | 0.03% | |
| 199 | Merus NV | 0.03% | |
| 200 | Recursion Pharmaceuticals Inc. Class A | 0.03% | |
| 201 | Protagonist Therapeutics Inc. | 0.03% | |
| 202 | Catalyst Pharmaceuticals Inc. | 0.03% | |
| 203 | Arcellx Inc. | 0.03% | |
| 204 | QuidelOrtho Corp. | 0.03% | |
| 205 | Geron Corp. | 0.03% | |
| 206 | Omnicell Inc. | 0.02% | |
| 207 | BioCryst Pharmaceuticals Inc. | 0.02% | |
| 208 | Pacira BioSciences Inc. | 0.02% | |
| 209 | Arvinas Inc. | 0.02% | |
| 210 | AtriCure Inc. | 0.02% | |
| 211 | Maravai LifeSciences Holdings Inc. Class A | 0.02% | |
| 212 | Xencor Inc. | 0.02% | |
| 213 | Silk Road Medical Inc. | 0.02% | |
| 214 | Ironwood Pharmaceuticals Inc. Class A | 0.02% | |
| 215 | Schrodinger Inc./United States | 0.02% | |
| 216 | Phreesia Inc. | 0.02% | |
| 217 | Owens & Minor Inc. | 0.02% | |
| 218 | Harmony Biosciences Holdings Inc. | 0.02% | |
| 219 | US Physical Therapy Inc. | 0.02% | |
| 220 | Avanos Medical Inc. | 0.02% | |
| 221 | Kura Oncology Inc. | 0.02% | |
| 222 | Innoviva Inc. | 0.02% | |
| 223 | Brookdale Senior Living Inc. | 0.02% | |
| 224 | Alphatec Holdings Inc. | 0.02% | |
| 225 | Keros Therapeutics Inc. | 0.02% | |
| 226 | Collegium Pharmaceutical Inc. | 0.02% | |
| 227 | CryoLife Inc. | 0.02% | |
| 228 | Immunovant Inc. | 0.02% | |
| 229 | Nurix Therapeutics Inc. | 0.02% | |
| 230 | Akero Therapeutics Inc. | 0.02% | |
| 231 | RxSight Inc. | 0.02% | |
| 232 | Ardelyx Inc. | 0.02% | |
| 233 | Mirum Pharmaceuticals Inc. | 0.02% | |
| 234 | ANI Pharmaceuticals Inc. | 0.02% | |
| 235 | Dynavax Technologies Corp. | 0.02% | |
| 236 | Vera Therapeutics Inc. Class A | 0.02% | |
| 237 | Apogee Therapeutics Inc. | 0.02% | |
| 238 | Arcutis Biotherapeutics Inc. | 0.02% | |
| 239 | Kiniksa Pharmaceuticals International plc Class A | 0.02% | |
| 240 | Prothena Corp. plc | 0.01% | |
| 241 | Sage Therapeutics Inc. | 0.01% | |
| 242 | Revance Therapeutics Inc. | 0.01% | |
| 243 | Pacific Biosciences of California Inc. | 0.01% | |
| 244 | Relay Therapeutics Inc. | 0.01% | |
| 245 | Fate Therapeutics Inc. | 0.01% | |
| 246 | Vir Biotechnology Inc. | 0.01% | |
| 247 | AdaptHealth Corp. | 0.01% | |
| 248 | Cassava Sciences Inc. | 0.01% | |
| 249 | CryoPort Inc. | 0.01% | |
| 250 | Cross Country Healthcare Inc. | 0.01% | |
| 251 | Nevro Corp. | 0.01% | |
| 252 | Verve Therapeutics Inc. | 0.01% | |
| 253 | Travere Therapeutics Inc. | 0.01% | |
| 254 | Alignment Healthcare Inc. | 0.01% | |
| 255 | Arcus Biosciences Inc. | 0.01% | |
| 256 | Establishment Labs Holdings Inc. | 0.01% | |
| 257 | CareDx Inc. | 0.01% | |
| 258 | Avid Bioservices Inc. | 0.01% | |
| 259 | Cytek Biosciences Inc. | 0.01% | |
| 260 | Aurinia Pharmaceuticals Inc. | 0.01% | |
| 261 | Anavex Life Sciences Corp. | 0.01% | |
| 262 | Emergent BioSolutions Inc. | 0.01% | |
| 263 | Allogene Therapeutics Inc. | 0.01% | |
| 264 | Enanta Pharmaceuticals Inc. | 0.01% | |
| 265 | Varex Imaging Corp. | 0.01% | |
| 266 | REGENXBIO Inc. | 0.01% | |
| 267 | Editas Medicine Inc. | 0.01% | |
| 268 | Atrion Corp. | 0.01% | |
| 269 | OPKO Health Inc. | 0.01% | |
| 270 | DocGo Inc. | 0.01% | |
| 271 | uniQure NV | 0.01% | |
| 272 | Fulgent Genetics Inc. | 0.01% | |
| 273 | Adaptive Biotechnologies Corp. | 0.01% | |
| 274 | BioLife Solutions Inc. | 0.01% | |
| 275 | Mesa Laboratories Inc. | 0.01% | |
| 276 | Simulations Plus Inc. | 0.01% | |
| 277 | ImmunityBio Inc. | 0.01% | |
| 278 | Cerus Corp. | 0.01% | |
| 279 | Enhabit Inc. | 0.01% | |
| 280 | Accolade Inc. | 0.01% | |
| 281 | Cogent Biosciences Inc. | 0.01% | |
| 282 | OrthoPediatrics Corp. | 0.01% | |
| 283 | Vanda Pharmaceuticals Inc. | 0.01% | |
| 284 | HealthStream Inc. | 0.01% | |
| 285 | Theravance Biopharma Inc. | 0.01% | |
| 286 | Castle Biosciences Inc. | 0.01% | |
| 287 | SI-BONE Inc. | 0.01% | |
| 288 | Viridian Therapeutics Inc. | 0.01% | |
| 289 | AngioDynamics Inc. | 0.01% | |
| 290 | Paragon 28 Inc. | 0.01% | |
| 291 | Clover Health Investments Corp. Class A | 0.01% | |
| 292 | Sana Biotechnology Inc. | 0.01% | |
| 293 | Alector Inc. | 0.01% | |
| 294 | AnaptysBio Inc. | 0.01% | |
| 295 | MaxCyte Inc. | 0.01% | |
| 296 | Replimune Group Inc. | 0.01% | |
| 297 | Surmodics Inc. | 0.01% | |
| 298 | Heron Therapeutics Inc. | 0.01% | |
| 299 | Health Catalyst Inc. | 0.01% | |
| 300 | Arcturus Therapeutics Holdings Inc. | 0.01% | |
| 301 | SIGA Technologies Inc. | 0.01% | |
| 302 | Treace Medical Concepts Inc. | 0.01% | |
| 303 | Quanterix Corp. | 0.01% | |
| 304 | GoodRx Holdings Inc. Class A | 0.01% | |
| 305 | iTeos Therapeutics Inc. | 0.01% | |
| 306 | Ocugen Inc. | 0.01% | |
| 307 | Community Health Systems Inc. | 0.01% | |
| 308 | Pennant Group Inc. | 0.01% | |
| 309 | Orthofix Medical Inc. | 0.01% | |
| 310 | Phibro Animal Health Corp. Class A | 0.01% | |
| 311 | OraSure Technologies Inc. | 0.01% | |
| 312 | Nuvation Bio Inc. | 0.01% | |
| 313 | Erasca Inc. | 0.01% | |
| 314 | Tango Therapeutics Inc. | 0.01% | |
| 315 | Stoke Therapeutics Inc. | 0.01% | |
| 316 | PetIQ Inc. Class A | 0.01% | |
| 317 | MiMedx Group Inc. | 0.01% | |
| 318 | Amneal Pharmaceuticals Inc. | 0.01% | |
| 319 | Humacyte Inc. | 0.01% | |
| 320 | Phathom Pharmaceuticals Inc. | 0.01% | |
| 321 | Zimvie Inc. | 0.01% | |
| 322 | Janux Therapeutics Inc. | 0.01% | |
| 323 | Y-mAbs Therapeutics Inc. | 0.01% | |
| 324 | Embecta Corp. | 0.01% | |
| 325 | Pliant Therapeutics Inc. | 0.01% | |
| 326 | Altimmune Inc. | 0.01% | |
| 327 | Tarsus Pharmaceuticals Inc. | 0.01% | |
| 328 | OmniAb Inc. | 0.01% | |
| 329 | MEDNAX Inc. | 0.01% | |
| 330 | 89bio Inc. | 0.01% | |
| 331 | Day One Biopharmaceuticals Inc. | 0.01% | |
| 332 | Sharecare Inc. | 0.01% | |
| 333 | Liquidia Technologies Inc. | 0.01% | |
| 334 | Disc Medicine Inc. | 0.01% | |
| 335 | MoonLake Immunotherapeutics Class A | 0.01% | |
| 336 | Evolus Inc. | 0.01% | |
| 337 | Enliven Therapeutics Inc. | 0.01% | |
| 338 | Fluidigm Corp. | 0.01% | |
| 339 | Harrow Inc. | 0.01% | |
| 340 | Cullinan Therapeutics Inc. | 0.01% | |
| 341 | Praxis Precision Medicines Inc. | 0.01% | |
| 342 | Edgewise Therapeutics Inc. | 0.01% | |
| 343 | 4D Molecular Therapeutics Inc. | 0.01% | |
| 344 | Spyre Therapeutics Inc. | 0.01% | |
| 345 | Immunome Inc. | 0.01% | |
| 346 | Ocular Therapeutix Inc. | 0.01% | |
| 347 | Soleno Therapeutics Inc. | 0.01% | |
| 348 | Longboard Pharmaceuticals Inc. | 0.01% | |
| 349 | EyePoint Pharmaceuticals Inc. | 0.01% | |
| 350 | Mind Medicine MindMed Inc. | 0.01% | |
| 351 | WaVe Life Sciences Ltd. | 0.01% | |
| 352 | Scholar Rock Holding Corp. | 0.01% | |
| 353 | Zymeworks Inc. | 0.01% | |
| 354 | Astria Therapeutics Inc. | 0.01% | |
| 355 | Olema Pharmaceuticals Inc. | 0.01% | |
| 356 | ORIC Pharmaceuticals Inc. | 0.01% | |
| 357 | ARS Pharmaceuticals Inc. | 0.01% | |
| 358 | Savara Inc. | 0.01% | |
| 359 | GRAIL Inc. | 0.01% | |
| 360 | FibroGen Inc. | 0% | |
| 361 | ModivCare Inc. | 0% | |
| 362 | Zentalis Pharmaceuticals Inc. | 0% | |
| 363 | Seres Therapeutics Inc. | 0% | |
| 364 | American Well Corp. Class A | 0% | |
| 365 | Nektar Therapeutics Class A | 0% | |
| 366 | Cutera Inc. | 0% | |
| 367 | Agenus Inc. | 0% | |
| 368 | Sangamo Therapeutics Inc. | 0% | |
| 369 | 2seventy bio Inc. | 0% | |
| 370 | Gossamer Bio Inc. | 0% | |
| 371 | Butterfly Network Inc. | 0% | |
| 372 | Multiplan Corp. | 0% | |
| 373 | Ventyx Biosciences Inc. | 0% | |
| 374 | Inovio Pharmaceuticals Inc. | 0% | |
| 375 | Coherus Biosciences Inc. | 0% | |
| 376 | RAPT Therapeutics Inc. | 0% | |
| 377 | Inogen Inc. | 0% | |
| 378 | Atea Pharmaceuticals Inc. | 0% | |
| 379 | Cara Therapeutics Inc. | 0% | |
| 380 | Pulmonx Corp. | 0% | |
| 381 | Eagle Pharmaceuticals Inc./DE | 0% | |
| 382 | ATAI Life Sciences NV | 0% | |
| 383 | CareMax Inc. | 0% | |
| 384 | Seer Inc. Class A | 0% | |
| 385 | Repare Therapeutics Inc. | 0% | |
| 386 | PMV Pharmaceuticals Inc. | 0% | |
| 387 | ALX Oncology Holdings Inc. | 0% | |
| 388 | MacroGenics Inc. | 0% | |
| 389 | IGM Biosciences Inc. | 0% | |
| 390 | MeiraGTx Holdings plc | 0% | |
| 391 | Organogenesis Holdings Inc. Class A | 0% | |
| 392 | Monte Rosa Therapeutics Inc. | 0% | |
| 393 | Century Therapeutics Inc. | 0% | |
| 394 | Aclaris Therapeutics Inc. | 0% | |
| 395 | Senseonics Holdings Inc. | 0% | |
| 396 | Entrada Therapeutics Inc. | 0% | |
| 397 | Aerovate Therapeutics Inc. | 0% | |
| 398 | Akoya Biosciences Inc. | 0% | |
| 399 | HilleVax Inc. | 0% | |
| 400 | Outset Medical Inc. | 0% | |
| 401 | 23andMe Holding Co. Class A | 0% | |
| 402 | Definitive Healthcare Corp. Class A | 0% | |
| 403 | Biomea Fusion Inc. | 0% | |
| 404 | Amylyx Pharmaceuticals Inc. | 0% | |
| 405 | Aldeyra Therapeutics Inc. | 0% | |
| 406 | Lyell Immunopharma Inc. | 0% | |
| 407 | Terns Pharmaceuticals Inc. | 0% | |
| 408 | Bionano Genomics Inc. | 0% | |
| 409 | Cabaletta Bio Inc. | 0% | |
| 410 | Prime Medicine Inc. | 0% | |
| 411 | ACELYRIN Inc. | 0% | |
| 412 | Mural Oncology plc | 0% | |
| 413 | SCILEX HOLDING CO - RESTRICTED LINE | 0% | |
| 414 | Cargo Therapeutics Inc. | 0% | |
| 415 | Korro Bio Inc. | 0% | |
| 416 | Dianthus Therapeutics Inc. | 0% |
Disclaimer
1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.
2. The information is not complete; for comprehensive data, please refer to the relevant websites.
3. All stock market data analyses are subject to survivorship bias.
